Position in AZN
as of Jun 30, 2026
· filed Jul 7, 2026
Position Value
$334,868
+$38,250 QoQ
Shares Held
1,766
+17.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#1,000
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026HARBOR INVESTMENT ADVISORY, LLC holds $39,325,998 across 14 Drug Manufacturers - General names. AZN ranks #8 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
10,157 | $12,182,611 | |
| 2 | JNJ |
Johnson & Johnson
|
41,765 | $10,607,057 | |
| 3 | AMGN |
Amgen Inc
|
22,827 | $8,266,113 | |
| 4 | ABBV |
AbbVie Inc.
|
19,981 | $5,028,018 | |
| 5 | MRK |
Merck & Co., Inc.
|
11,386 | $1,463,101 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
8,368 | $482,164 | |
| 7 | NVO |
Novo Nordisk A S
|
8,678 | $416,023 | |
| 8 | AZN |
Astrazeneca PLC
This page
|
1,766 | $334,868 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $334,868 | 1,766 | Shares | Sole | 2026-07-07 | |
| 2026-03-31 | $296,618 | 1,504 | Shares | Sole | 2026-04-23 | |
| No filing history on record for this holder in this stock. | ||||||